(Q36886282)

16 August 2017

0 references

A meta-analysis of the placebo response in complementary and alternative medicine trials of irritable bowel syndrome (English)

1 reference

16 August 2017

S D Dorn

1

1 reference

16 August 2017

T J Kaptchuk

2

1 reference

16 August 2017

J B Park

3

1 reference

16 August 2017

L T Nguyen

4

1 reference

16 August 2017

K Canenguez

5

1 reference

16 August 2017

B H Nam

6

1 reference

16 August 2017

K B Woods

7

1 reference

16 August 2017

L A Conboy

8

1 reference

16 August 2017

W B Stason

9

1 reference

16 August 2017

A J Lembo

10

1 reference

16 August 2017

publication date

1 August 2007

1 reference

Neurogastroenterology and Motility

16 August 2017

published in

1 reference

16 August 2017

volume

19

1 reference

16 August 2017

issue

8

1 reference

16 August 2017

page(s)

630-637

1 reference

Powerful placebo: the dark side of the randomised controlled trial.

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Concept of true and perceived placebo effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Do medical devices have enhanced placebo effects?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Do certain countries produce only positive results? A systematic review of controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Effect of colour of drugs: systematic review of perceived effect of drugs and of their effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Placebo effect in the treatment of duodenal ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Defining the predictors of the placebo response in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Placebo effect in the acute treatment of migraine: subcutaneous placebos are better than oral placebos

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

The placebo effect in alternative medicine: can the performance of a healing ritual have clinical significance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Magnitude of placebo response and drug-placebo differences across psychiatric disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

AGA technical review on irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Treatment of irritable bowel syndrome: a review of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

The placebo effect in irritable bowel syndrome trials: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Problems and challenges in the design of irritable bowel syndrome clinical trials: experience from published trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

The placebo response in functional bowel disorders: perspectives and putative mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Alternative medicine use by Canadian ambulatory gastroenterology patients: secular trend or epidemic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Use of complementary therapies by patients with IBD may indicate psychosocial distress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

A systematic review of alternative therapies in the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Systematic review: Complementary and alternative medicine in the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Unconventional medicine in the United States. Prevalence, costs, and patterns of use

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Effectiveness of the Chinese herbal formula TongXieYaoFang for irritable bowel syndrome: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Where does hypnotherapy stand in the management of irritable bowel syndrome? A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Complementary and alternative medicine for functional gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Systematic review: the effectiveness of hypnotherapy in the management of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

What is meant by intention to treat analysis? Survey of published randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Language bias in randomised controlled trials published in English and German.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Treatment of irritable bowel syndrome with herbal preparations: results of a double-blind, randomized, placebo-controlled, multi-centre trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

A novel treatment for constipation-predominant irritable bowel syndrome using Padma Lax, a Tibetan herbal formula

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Herbal medicine with curcuma and fumitory in the treatment of irritable bowel syndrome: a randomized, placebo-controlled, double-blind clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Acupuncture for irritable bowel syndrome: a blinded placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herbal medicine: a randomized placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Melatonin improves bowel symptoms in female patients with irritable bowel syndrome: a double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Modelling publication bias in meta-analysis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Location bias in controlled clinical trials of complementary/alternative therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Challenges in systematic reviews of complementary and alternative medicine topics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Alternative therapy bias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

A meta-analysis of the placebo rates of remission and response in clinical trials of active Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Quantification of the placebo response in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Cultural variations in the placebo effect: ulcers, anxiety, and blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Meta-analysis: statistical alchemy for the 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Is there logic in the placebo?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Design of treatment trials for functional gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

Outcome measures in irritable bowel syndrome: comparison of psychometric and methodological characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00937.X

10.1111/J.1365-2982.2007.00937.X

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference